AU4862296A - Methods of decreasing serum calcium levels - Google Patents
Methods of decreasing serum calcium levelsInfo
- Publication number
- AU4862296A AU4862296A AU48622/96A AU4862296A AU4862296A AU 4862296 A AU4862296 A AU 4862296A AU 48622/96 A AU48622/96 A AU 48622/96A AU 4862296 A AU4862296 A AU 4862296A AU 4862296 A AU4862296 A AU 4862296A
- Authority
- AU
- Australia
- Prior art keywords
- calcium levels
- serum calcium
- methods
- decreasing serum
- decreasing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052791 calcium Inorganic materials 0.000 title abstract 2
- 239000011575 calcium Substances 0.000 title abstract 2
- 210000002966 serum Anatomy 0.000 title abstract 2
- 230000003247 decreasing effect Effects 0.000 title 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- -1 hexamethylene imino Chemical group 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 abstract 1
- 229960004622 raloxifene Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N thianaphthalene Natural products C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Liquid Crystal Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Abstract
Lowering serum calcium levels comprises admin. of 2-phenyl-3-aroyl benzothiophene deriv. of formula (I) or its salt or solvate. R1, R3 = H, Me, COAr or 1-6C alkoxy; Ar = opt. substd. Ph; R2 = pyrrolidine, hexamethylene imino or piperidino. (I) is pref. raloxifene.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/380881 | 1995-01-30 | ||
US08/380,881 US5512583A (en) | 1995-01-30 | 1995-01-30 | Methods of decreasing serum calcium levels |
PCT/US1996/001406 WO1996023501A1 (en) | 1995-01-30 | 1996-01-29 | Methods of decreasing serum calcium levels |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4862296A true AU4862296A (en) | 1996-08-21 |
AU701262B2 AU701262B2 (en) | 1999-01-21 |
Family
ID=23502813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU48622/96A Ceased AU701262B2 (en) | 1995-01-30 | 1996-01-29 | Methods of decreasing serum calcium levels |
Country Status (19)
Country | Link |
---|---|
US (1) | US5512583A (en) |
EP (1) | EP0723780B1 (en) |
JP (1) | JPH10513184A (en) |
KR (1) | KR19980701731A (en) |
CN (1) | CN1086943C (en) |
AT (1) | ATE216232T1 (en) |
AU (1) | AU701262B2 (en) |
CA (1) | CA2211530A1 (en) |
CZ (1) | CZ286161B6 (en) |
DE (1) | DE69620661T2 (en) |
DK (1) | DK0723780T3 (en) |
ES (1) | ES2172633T3 (en) |
HU (1) | HUP9801335A3 (en) |
NO (1) | NO973470L (en) |
NZ (1) | NZ302546A (en) |
PT (1) | PT723780E (en) |
RU (1) | RU2176503C2 (en) |
UA (1) | UA43389C2 (en) |
WO (1) | WO1996023501A1 (en) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
JP3157882B2 (en) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | New benzothiophene derivatives |
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
DE4320896A1 (en) * | 1993-06-24 | 1995-01-05 | Denecke Rainer Dr Med Vet | Product for the therapy and prophylaxis of dementias |
US5478847A (en) * | 1994-03-02 | 1995-12-26 | Eli Lilly And Company | Methods of use for inhibiting bone loss and lowering serum cholesterol |
TW398975B (en) * | 1994-07-22 | 2000-07-21 | Lilly Co Eli | Pharmaceutical composition for inhibiting bone loss |
-
1995
- 1995-01-30 US US08/380,881 patent/US5512583A/en not_active Expired - Fee Related
-
1996
- 1996-01-29 AT AT96300610T patent/ATE216232T1/en not_active IP Right Cessation
- 1996-01-29 ES ES96300610T patent/ES2172633T3/en not_active Expired - Lifetime
- 1996-01-29 JP JP8523733A patent/JPH10513184A/en not_active Withdrawn
- 1996-01-29 NZ NZ302546A patent/NZ302546A/en unknown
- 1996-01-29 WO PCT/US1996/001406 patent/WO1996023501A1/en not_active Application Discontinuation
- 1996-01-29 UA UA97074027A patent/UA43389C2/en unknown
- 1996-01-29 DK DK96300610T patent/DK0723780T3/en active
- 1996-01-29 CA CA002211530A patent/CA2211530A1/en not_active Abandoned
- 1996-01-29 AU AU48622/96A patent/AU701262B2/en not_active Ceased
- 1996-01-29 RU RU97114794/14A patent/RU2176503C2/en active
- 1996-01-29 EP EP96300610A patent/EP0723780B1/en not_active Expired - Lifetime
- 1996-01-29 PT PT96300610T patent/PT723780E/en unknown
- 1996-01-29 CN CN96191671A patent/CN1086943C/en not_active Expired - Fee Related
- 1996-01-29 DE DE69620661T patent/DE69620661T2/en not_active Expired - Fee Related
- 1996-01-29 CZ CZ19972403A patent/CZ286161B6/en not_active IP Right Cessation
- 1996-01-29 HU HU9801335A patent/HUP9801335A3/en unknown
- 1996-01-29 KR KR1019970705127A patent/KR19980701731A/en not_active Application Discontinuation
-
1997
- 1997-07-28 NO NO973470A patent/NO973470L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE216232T1 (en) | 2002-05-15 |
EP0723780A2 (en) | 1996-07-31 |
AU701262B2 (en) | 1999-01-21 |
NZ302546A (en) | 2000-06-23 |
WO1996023501A1 (en) | 1996-08-08 |
DE69620661D1 (en) | 2002-05-23 |
DE69620661T2 (en) | 2002-11-14 |
KR19980701731A (en) | 1998-06-25 |
CZ240397A3 (en) | 1998-01-14 |
HUP9801335A2 (en) | 1999-05-28 |
JPH10513184A (en) | 1998-12-15 |
EP0723780B1 (en) | 2002-04-17 |
DK0723780T3 (en) | 2002-06-17 |
US5512583A (en) | 1996-04-30 |
NO973470D0 (en) | 1997-07-28 |
CA2211530A1 (en) | 1996-08-08 |
CN1172432A (en) | 1998-02-04 |
MX9705697A (en) | 1997-10-31 |
CN1086943C (en) | 2002-07-03 |
EP0723780A3 (en) | 1996-09-11 |
HUP9801335A3 (en) | 2000-03-28 |
PT723780E (en) | 2002-08-30 |
CZ286161B6 (en) | 2000-01-12 |
ES2172633T3 (en) | 2002-10-01 |
RU2176503C2 (en) | 2001-12-10 |
NO973470L (en) | 1997-07-28 |
UA43389C2 (en) | 2001-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7579094A (en) | Methods for the treatment of peri-menopausal syndrome | |
SI1465861T1 (en) | Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors | |
DE69332735D1 (en) | Use of benzothiophenes for the treatment of hypercholesterolemia | |
AU8155894A (en) | Methods of inhibiting thrombin | |
AU6530896A (en) | Pyrrolidine derivatives having phospholipase a2 inhibitory activity | |
GB0318343D0 (en) | No title | |
AU7578794A (en) | Methods for inhibiting endometriosis | |
AU7583494A (en) | Methods of inhibiting uterine fibrosis | |
AU8156394A (en) | Methods for inhibiting LDL oxidation and atheroclerosis | |
AU8156194A (en) | Methods of inhibiting dysfunctional uterine bleeding | |
AU7578994A (en) | Methods for inhibiting cartilage degradation | |
AU7578694A (en) | Methods for treating resistant neoplasms | |
AU6335194A (en) | Method for producing benzylidene derivatives | |
AU4862296A (en) | Methods of decreasing serum calcium levels | |
AU1710797A (en) | Methods of modulating radical formation by mutant cuznsod enzymes | |
AU6985796A (en) | Method of producing dihydroxypyrimidine derivatives | |
HU9600914D0 (en) | 4-indolylpiperazinyl derivatives | |
UA26459C2 (en) | INHIBITOR OF INFLUENCE OF AMYLOID PROTEINS | |
AP9600800A0 (en) | 2-(Pyrazol-3-yl) carbapenem derivatives. | |
EP0711554A4 (en) | Antidepressant | |
AU3409895A (en) | Methods of inhibiting primary endometrial hyperplasia | |
PL322004A1 (en) | Novel e. coli mutant of inhibited production or organic acids | |
EP0859758A4 (en) | ||
HUP9902712A2 (en) | Methods of increasing nitric oxide synthesis | |
MX9710147A (en) | Herpes ribonucleotide reductase inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |